Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Incorporating biomarkers into drug labeling.

Clinical advances in hematology & oncology : H&O - 1 Aug 2014

Ratain Mark J

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Biomarkers
Share to Biomarkers, Tumor
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25356576

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Incorporating biomarkers into drug labeling.PMID 25356576Read ↗

Using imaging biomarkers to accelerate drug development and clinical trials.Semantic proximity Read ↗

New Serious Safety Warnings of Targeted Anticancer Agents After Their Initial FDA ApprovalSemantic proximity Read ↗

Impact of the NCCN biomarkers compendium on managed care pharmacy.Semantic proximity Read ↗

CSL-Tox: An open-source analytical framework for the comparison of short-term and long-term toxicity end points and exploring the opportunities for decreasing in-vivo studies conducted for drug development programsSemantic proximity Read ↗

A Decision Support System for Preclinical Assessment of Nanomaterials in Medical Products: The REFINE DSSSemantic proximity Read ↗

Drug development: Mix and match.Semantic proximity Read ↗

Strategic Objectives of Nanotechnology-Driven Repurposing in Radiopharmacy. Implications for Radiopharmaceutical Repurposing (Beyond Oncology)Semantic proximity Read ↗

Noninvasive imaging in drug discovery and development.Semantic proximity Read ↗

Breath tests to phenotype drug disposition in oncology.Semantic proximity Read ↗

Combining label-free cell phenotypic profiling with computational approaches for novel drug discovery.Semantic proximity Read ↗

[Molecular imaging for drug development].Semantic proximity Read ↗

A Critical Analysis of the FDA Omics Perspective on Pharma-codynamic Biomarkers to Support Biosimilarity, and its Surrogates.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.